[Clinical characteristics of patients referred to cardio-oncology clinic]

Zhonghua Yi Xue Za Zhi. 2023 Jul 25;103(28):2183-2186. doi: 10.3760/cma.j.cn112137-20221108-02348.
[Article in Chinese]

Abstract

To explore characteristics of outpatients in a single cardio-oncology clinic, patients visiting cardio-oncology clinic of Fuwai Hospital CAMS&PUMC (Beijing, China) from January 2020 to December 2021 were analyzed retrospectively. In total, 330 patients were included, the median age (Q1, Q3) was 58(46, 66) years, and there were 192 females (58.2%). The purposes for visit included an evaluation and treatment of cardiovascular adverse reactions (n=247, 74.8%), pre-antitumor therapy assessment (n=51, 15.5%), and management of primary or metastatic cardiac tumors (n=32, 9.7%). For patients with cardiovascular adverse reactions, the most common tumor type was breast cancer (n=88, 29.5%), followed by gastrointestinal cancer (n=70, 23.5%), and hematological cancers (n=62, 20.8%). Among them, 236 cases (95.5%) had received antitumor drugs in the past; 38 cases (15.4%) had a history of chest radiotherapy; some cases were complicated with hypertension (n=69, 23.2%) and/or hyperlipidemia (n=69, 23.2%); 42 cases (14.1%) had a history of coronary heart disease; and 16 cases (5.4%) were complicated with atrial fibrillation or flutter. Among 32 patients with cardiac tumors, 11 cases (34.4%) had primary malignant tumors; 6 cases (18.8%) had benign tumors; 2 cases (6.3%) had metastatic tumors; and 13 (40.6%) had unknown pathological types. This study explores the epidemiology of cardio-oncology in China and provides clinical insights for the future development of cardio-oncology. In the future, it is still necessary to study the benefits of cardio-oncology clinics and develop standardized indicators to evaluate their benefits.

为探讨肿瘤心脏病门诊患者的流行病学特征,本研究回顾性收集并分析2020—2021年于中国医学科学院阜外医院肿瘤心脏病门诊就诊的患者资料,共纳入330例患者,年龄[MQ1Q3)]为58(46,66)岁,其中女性192例(58.2%)。患者就诊目的包括心血管不良反应的评估与处理(247例,74.8%)、抗肿瘤治疗风险评估(51例,15.5%)、心脏原发或转移性肿瘤的治疗与对症处理(32例,9.7%)。对于出现心血管不良反应的患者,最常见原发肿瘤类型为乳腺癌(88例,29.5%),其次是胃肠道癌(70例,23.5%)、血液系统肿瘤(62例,20.8%)等;其中既往接受肿瘤用药者236例(95.5%),有胸部放疗史者38例(15.4%),部分患者合并高血压(69例,23.2%)和(或)高血脂(69例,23.2%),42例(14.1%)有冠状动脉粥样硬化性心脏病史,16例(5.4%)合并心房颤动/心房扑动。在32例心脏肿瘤患者中,心脏原发恶性肿瘤11例(34.4%),原发良性肿瘤6例(18.8%),转移性肿瘤2例(6.3%),13例(40.6%)病理分型不明。研究发现本中心肿瘤心脏病门诊患者最常见的就诊目的是心血管不良反应的评估与处理,最常见原发肿瘤类型为乳腺癌,既往大部分接受了肿瘤用药,且部分患者合并心血管病史。.

Publication types

  • English Abstract

MeSH terms

  • Aged
  • Antineoplastic Agents* / adverse effects
  • Breast Neoplasms* / complications
  • Breast Neoplasms* / therapy
  • Female
  • Heart Neoplasms* / chemically induced
  • Heart Neoplasms* / complications
  • Humans
  • Male
  • Medical Oncology
  • Middle Aged
  • Retrospective Studies

Substances

  • Antineoplastic Agents